Idiopathic retroperitoneal fibrosis: Prospective evaluation of incidence and clinicoradiologic presentation

Medicine

Volumn 88, Issue 4, 2009, Pages 193-201

  Van Bommel, E F H ^a   Jansen, I ^a   Hendriksz, T R ^a   Aarnoudse, A L H J ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; ASBESTOS;

ABDOMINAL PAIN; ADULT; AGED; AORTA ANEURYSM; ARTICLE; ASBESTOSIS; BACKACHE; BODY MASS; BODY SURFACE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLANK PAIN; HEMATOCRIT; HISTOLOGY; HUMAN; HYDROCELE; HYDRONEPHROSIS; HYPERTENSION; IDIOPATHIC DISEASE; INCIDENCE; INFLAMMATORY DISEASE; LEUKOCYTE COUNT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MASS RADIOGRAPHY; MORBIDITY; NAUSEA; ONSET AGE; PAIN ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROPERITONEAL FIBROSIS; SCROTAL PAIN; SMOKING; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION; URINARY FREQUENCY; VISUAL ANALOG SCALE; VOMITING; WEIGHT REDUCTION; BLOOD; COHORT ANALYSIS; HOSPITALIZATION; MIDDLE AGED; PAIN; PROSPECTIVE STUDY; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

AGED; ASBESTOS; BLOOD SEDIMENTATION; COHORT STUDIES; FEMALE; HUMANS; HYDRONEPHROSIS; INCIDENCE; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651083578     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181afc420     Document Type: Article

References (38)

1. Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC. Presence of asbestos bodies in organs other than the lung. Chest. 1980;77:133-137.
2. Baker LR, Mallinson WJ, Gregory MC, Menzies EA, Cattell WR, Whitfield HN, Hendry WF, Wickham JE, Joekes AM. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol. 1987;60:497-503.
3. Baker LRI. Auto-allergic periaortitis (idiopathic retroperitoneal fibrosis) [Editorial comment]. BJU Int. 2003;92:663-665.
4. Brooks AP Computed tomography of idiopathic retroperitoneal fibrosis ("periaortitis"): variants, variations, patterns and pitfalls. Clin Radiol. 1990;42:75-79.
5. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, Ferretti S, Cobelli R, Moroni G, Dei Tos AP, Buzio C, Vaglio A. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007;72:742-753.
6. Cottin V, Brillet PY, Combarnous F, Duperron F, Nunes H, Cordier JF Syndrome of pleural and retrosternal bridging fibrosis and retroperitoneal fibrosis in patients with asbestos exposure. Thorax. 2008;63:177-179.
7. Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Myhre HO. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg. 2003;38:492-497.
8. Higgins PM. Retroperitoneal fibrosis. An update. Dig Dis. 1991;8:206-222.
9. Higgins PM, Bennett-Jones DN, Naish PF, Aber G. Non-operative management of retroperitoneal fibrosis. Br J Surg. 1988;75:573-577.
10. Ilie CP, Pemberton RJ, Tolley DA. Idiopathic retroperitoneal fibrosis: the case for non-surgical treatment. Br J Urol. 2005;98:137-140.
11. Jois RN, Gaffney K, Marshall T, Scott DG. Chronic periaortitis. Rheumatology (Oxford). 2004;43:1441-1446.
12. Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery. 1977;81:250-257.
13. Lederle J, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy FN. Relationship of age, gender, race, and body size to infrarenal aortic diameter. Vasc Surg. 1997;26:595-601.
14. Lepor H, Walsh PC. Idiopathic retroperitoneal fibrosis. J Urol. 1979;122:1-6.
15. Maillefert JF, Pfitzenmeyer P, Thenet M, Olsson NO, Piroth C, Behin A, Tavernier C, Justrabo E. Prevalence of ANCA in a hospitalized elderly French population. Clin Exp Rheumatol. 1997;15:603-607.
16. Marcolongo R, Tavolini IM, Laveder F, Busa M, Noventa F, Bassi P, Semenzato G. Immunosuppresive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. 2004;116:194-197.
17. *03: another clue to an autoimmune origin. Arthitis Rheum. 2006;55:126-130.
18. Mitchinson Ml Retroperitoneal fibrosis revisited. Arch Pathol Lab Med. 1986;10:784-786.
19. Nakajo M, Jinnouchi S, Tanabe H, Tateno R, Nakajo M. 18F- fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis. J Comput Assist Tomogr. 2007;31:539-543.
20. Nitecki SS, Hallett JW, Stanson AW, Ilstrup DM, Bower TC, Cherry KJ, Gloviczki P, Pairolero PC. Inflammatory abdominal aneurysms: a case-control study. J Vasc Surg. 1996;23:860-869.
21. Norman P, Le M, Pearce C, Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol. 2004;24:1278-1282.
22. Parums DV The spectrum of chronic periaortitis. Histopathology. 1990;16:423-431.
23. Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine (Baltimore). 2009;88:202-207.
24. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997;40:1601-1611.
25. Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stolzel U. [Prevalence of circulating autoantibodies in healthy individuals]. Med Klin (Munich). 2002;97:645-649.
26. Tunc R, Gonen MS, Acbay O, Hamuryudan V, Yazici H. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Ann Rheum Dis. 2004;63:575-577.
27. Uibu T, Oksa P, Auvinen A, Honkanen E, Metsarinne K, Saha H, Uitti J, Roto P. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363:1422-1426.
28. Vaglio A. Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis [Commentary]. Medicine (Baltimore). 2009;88:208-210.
29. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241-251.
30. Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med. 2003;114:454-462.
31. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, Salvarani C, Buzio C. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of 5 cases and review of the literature. Rheumatology (Oxford). 2008;47:315-318.
32. Van Bommel EFH, Brouwers A, Makkus A, van Vliet A. Retroperitoneal fibrosis and p-ANCA-associated polyarteritis nodosa: coincidental or common etiology? Eur J Intern Med. 2002;13:392-395.
33. Van Bommel EFH. Retroperitoneal fibrosis. Neth J Med. 2002;60:231-242.
34. Van Bommel EFH, Siemes C, van der Veer SJ, Han SH, Huiskes AWLC, Hendriksz TR. Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis. A prospective study. J Intern Med. 2007;262:224-234.
35. Vivas I, Nicolas AI, Velazquez P, Elduayen B, Fernandez-Villa T, Martinez-Cuesta A. Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol. 2000;73:214-222.
36. Wagenknecht LV Auvert J. Symptoms and diagnosis of retroperitoneal fibrosis. Urol Int. 1971;26:185-195.
37. Warnatz K, Keskin AG, Uhl M, Scholz C, Katzenwadel A, Vaith P, Peter HH, Walker UA. Immunosuppressive treatment of chronic peri-aortitis: a retrospective study of 20 patients and a review of the literature. Ann Rheum Dis. 2005;64:828-833.
38. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13:227-236.